New eye health companies gain funders’ focus

Startups pioneering less-invasive technologies to treat common eye diseases are changing the outlook for both patients and the industry.

A new study by CB Insights revealed that investors have been pouring money into smaller companies in 2017 and 2018, with some FDA approvals to begin marketing their technologies and treatments.